| Title | Description |
|
PROVIDE trial
| A PERSONALIZED RANDOMIZED TRIAL OF VALIDATION AND RESTORATION OF IMMUNE DYSFUNCTION IN SEVERE INFECTIONS AND SEPSIS |
|
SAVE-MORE trial
| suPAR-GUIDED ANAKINRA TREATMENT FOR VALIDATION OF THE RISK AND EARLY MANAGEMENT OF SEVERE RESPIRATORY FAILURE BY COVID-19:
THE SAVE-MORE DOUBLE-BLIND, RANDOMIZED, PHASE III CONFIRMATORY TRIAL |
|
IMMUNOSEP trial
| PERSONALIZED IMMUNOTHERAPY IN SEPSIS: A MULTICENTRE AND MULTINATIONAL, DOUBLE-BLIND, DOUBLE-DUMMY RANDOMIZED CLINICAL TRIAL |
|
Η ΜΕΛΕΤΗ BEYOND
| Η ΑΠΟΤΕΛΕΣΜΑΤΙΚΟΤΗΤΑ ΤΗΣ ΜΠΕΖΛΟΤΟΞΟΥΜΑΜΠΗΣ
ΣΤΙΣ ΕΞΑΤΟΜΙΚΕΥΜΕΝΕΣ ΑΝΑΓΚΕΣ ΑΣΘΕΝΩΝ ΜΕ ΛΟΙΜΩΞΗ
ΑΠΟ CLOSTRIDIOIDES DIFFICILE |
|
ACCESS trial
| A randomized clinical trial of oral Clarithromycin in Community-acquired pneumonia
to attenuatE inflammatory responseS and improve outcomeS |
|
INSPIRE trial
| IMMUNOTHERAPY NAVIGATED BY SERUM
PRESEPSIN FOR INFECTIONS OF THE RESPIRATORY TRACT:
THE INSPIRE DOUBLE-BLIND, RANDOMIZED, PHASE IIa EXPLORATORY TRIAL |
|
MODIFY trial
| A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND
MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE INFECTIONS |
|
PRECISION trial
| Safety and efficacy of Anakinra treatment for patients with
Persistent REspiratory symptoms post acute COVID and Immune System activatION
The PRECISION double-blind, randomized clinical trial |
|
BioArte trial
| DEVELOPMENT OF A NON-INTERVENTIONAL DIAGNOSTIC NGS-BASED ASSAY OF BLOOD SAMPLES OF SEPSIS PATIENTS FOR RAPID BACTERIAL IDENTIFICATION BASED ON NEXT GENERATION SEQUENCING |
|
REACT trial
| BIOMARKER-GUIDED EARLY CLARITHROMYCIN TREATMENT TO
PREVENT SEPSIS PROGRESSION IN COMMUNITY-ACQUIRED
PNEUMONIA: THE REACT RANDOMIZED CLINICAL TRIAL |